Inverse Association between Birth Weight and C-Reactive Protein Concentrations in the MIDSPAN Family Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 3, 2004, Pages 583-587

  Sattar, Naveed ^a   McConnachie, Alex ^b   O'Reilly, Denis ^a   Upton, Mark N ^b,c   Greer, Ian A ^a   Davey Smith, George ^c   Watt, Graham ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Birth weight; C reactive protein; Fetal programming; Inflammation; Obesity

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HEREDITY; HUMAN; INFLAMMATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOCIOECONOMICS;

ADULT; AGE FACTORS; BIRTH WEIGHT; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SCOTLAND; SMOKING; SOCIOECONOMIC FACTORS;

EID: 1542373705     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000118277.41584.63     Document Type: Article

References (30)

1. Barker DJ. Fetal origins of cardiovascular disease. Ann Med. 1999; 31:3-6.
2. Barker DJ. The fetal origins of type 2 diabetes mellitus. Ann Intern Med. 1999;130:322-324.
3. Huxley R, Neil A, Collins R. Unravelling the fetal origins hypothesis: is there really an inverse association between birth weight and subsequent blood pressure? Lancet. 2002;360:659-665.
4. Owen CG, Whincup PH, Odoki K, Gilg JA, Cook DG. Birth weight and blood cholesterol level: a study in adolescents and systematic review. Pediatrics. 2003;111:1081-1089.
5. Newsome CA, Shiell AW, Fall CH, Phillips DI, Shier R, Law CM. Is birth weight related to later glucose and insulin metabolism?-a systematic review. Diabet Med. 2003;20:339-348.
6. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr., Taubert K, Tracy RP, Vinicor F, Centers for Disease Control and Prevention. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the Am Heart Association. Circulation. 2003;107:499-511.
7. Freeman DJ, Norrie J, Caslake M, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N. C-reactive protein is an independent predictor of risk for the development of diabetes mellitus in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51:1596-1600.
8. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing diabetes mellitus. JAMA. 2001;286:327-334.
9. Palinski, W. New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol. 2001;21:3-5.
10. Gullestad L, Aukrust P, Ueland T, Espevik T, Yee G, Vagelos R, Froland SS, Fowler M. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol. 1999;34:2061-2067.
11. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:82-86.
12. Upton MN, McConnachie A, McSharry C, Hart CL, Smith GD, Gillis CR, Watt GC. Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ. 2000;321:88-92.
13. Hawthorne VM, Watt GCM, Hart CL, Hart CL, Smith GD, Gillis CR, Watt GC. Cardiorespiratory disease in men and women in urban Scotland: baseline characteristics of the Renfrew/Paisley (Midspan) study population. Scot Med J. 1995;40:102-107.
14. Davey Smith G, Hart C, Ferrell C, Upton M, Hole D, Hawthorne V, Watt G. Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. BMJ. 1997;315:1189-1193.
15. Carstairs V, Morris R. Deprivation and health in Scotland. Aberdeen: Aberdeen University Press; 1991.
16. Lowe GD, Upton MN, Rumley A, McConnachie A, O'Reilly DS, Watt GC. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein-a cross-sectional population survey. Thromb Haemost. 2001;86: 550-556.
17. Smith DM, Robertson WH, Diggle PJ. Oswald: Object-Oriented Software for the Analysis of Longitudinal Data in S, Technical Report MA 96/192, Department of Mathematics and Statistics, University of Lancaster, LA1 4YF, United Kingdom, 1996.
18. Zeger SL, Liang KY. Longitudinal Data Analysis for Discrete and Continuous Outcomes. Biometrics. 1986;42:121-130.
19. Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican Am children. J Natl Med Assoc. 2003;95:545-552.
20. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139-150.
21. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular and inflammatory pathways. J Clin Endocrinol Metab. 2002;87: 4231-4237.
22. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51: 2207-2213.
23. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K, Holmang A. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol. 2001;281:E326-E334.
24. Tomaszewski M, Charchar FJ, Przybycin M, Crawford L, Wallace AM, Gosek K, Lowe GD, Zukowska-Szczechowska E, Grzeszczak W, Sattar N, Dominiczak AF. Strikingly Low Circulating CRP Concentrations in Ultramarathon Runners Independent of Markers of Adiposity: How Low Can You Go? Arterioscler Thromb Vasc Biol. 2003;23:1640-1644.
25. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105:1785-1790.
26. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease - the hypothesis revisited. BMJ. 1999;319:245-249.
27. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972-978.
28. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without CRP as a predictor of CHD and diabetes in West of Scotland Coronary Prevention Study. Circulation. 2003;108: 414-419.
29. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy Am women. Circulation. 2003;107: 391-397.
30. Davey Smith G, Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22.